Ranbaxy Laboratories said on Thursday it has launched the first generic version of the cholesterol-lowering Lipitor in the U.S., the largest selling drug of all time, sending its shares surging over 11 percent.
Stock index futures pointed to a weaker open on Wall Street on Thursday, with futures for the S&P 500 down 0.5 percent, Dow Jones futures down 0.4 percent and Nasdaq 100 futures down 0.2 percent at 4:37 a.m. ET.
As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the 3 million Americans who take the biggest-selling drug of all time.
Pfizer Inc. will see the end of a hugely lucrative era on Wednesday, Nov. 30, when its two-decade old patent for Lipitor, a hugely popular drug for cholesterol management, expires.
U.S-based multinational corporations added almost 3 million jobs to their payrolls in foreign countries between 1999 and 2009, while slashing 864,600 jobs at home, as they become increasingly dependent on foreign sales. Is tax holiday a viable solution?
Kenneth Kies sizes up the chances of reforming the convoluted U.S. tax code like someone who has lived through it before. In fact, he has.
Pfizer Inc. agreed to buy privately held biopharmaceutical company Excaliard Pharmaceuticals for an undisclosed sum, to gain access to Excaliard's experimental skin scarring drug.
More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday.
Pfizer Inc won expert backing for using its blockbuster vaccine in adults to fight pneumonia, meningitis and other diseases caused by pneumococcus bacteria.
Pfizer Inc won expert backing for using its blockbuster vaccine in adults to fight pneumonia, meningitis and other diseases caused by pneumococcus bacteria.
Members of Congress' super committee responsible for slicing $1.2 trillion from the deficit have faced an intense lobbying push since being appointed to the 12-member panel, but they all have long histories of accepting money from the industries and special interest groups clamoring for a seat at the table.
Hedge fund manager David Einhorn exited Pfizer
, his largest holding, and made new bets on CBS Corp ., General Motors Co and Marvell Technology Group during the third quarter.
Americans in the past year got access to 24 new medicines before they became available anywhere else, U.S. drug regulators said.
Britain's GlaxoSmithKline has agreed to pay billions of dollars to settle multiple U.S. pharmaceutical investigations.
Researchers called Chantix, the smoking-cessation drug linked to psychotic and suicidal side effects, unsafe for patients Wednesday; just days after federal health officials in October deemed the drug safe.
Pfizer Inc., the world's largest drug maker, reported third-quarter profit that topped analysts' expectations based on U.S. growth of their cholesterol block-buster drug Lipitor, favorable foreign exchange rates and increases in overseas sales.
Pfizer Inc's quarterly results came in much better than expected, as sales of its medicines accelerated in emerging markets and in the nutritional products and animal health businesses it plans to divest.
Pfizer Inc reported better-than-expected quarterly results, helped by the weaker dollar and strong performance of the nutritionals and animal health businesses it plans to sell or spin off.
Stock index futures tumbled on Tuesday as the deal to rescue Greece and prevent a wider sovereign debt crisis faced a new hurdle and as Asian economic data reignited fears of a slowdown in global growth.
Stock index futures tumbled on Tuesday as the deal to rescue Greece and prevent a wider sovereign debt crisis faced a new hurdle and as Asian economic data reignited fears of a slowdown in global growth.
Futures pointed to a lower open on Wall Street on Tuesday, adding to losses in the previous session, with the shock announcement of a Greek referendum on its bailout dragging down markets worldwide.
The companies that are expected to see active trade on Tuesday are: Archer-Daniels-Midland, CME Group, Pfizer, Baker Hughes, Emerson Electric, General Cable, Discovery Communications, Fiserv, Rogers Corp, Fidelity National Information Services, Jds Uniphase Corp. and Tenet Healthcare Corp.